Mosaic ImmunoEngineering Inc. (CPMV) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US61945M1018

Price
0.06 USD
Market cap
434,186.82 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Mosaic ImmunoEngineering Inc. financials

Fiscal year2025
Operating income-616,119.00 USD
EBIT-675,445.00 USD
Net income-687,846.00 USD
Diluted EPS – continuing operations-0.10 USD

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. The company engages in pursuing new product candidates and platforms to build a pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.